Literature DB >> 33229347

Anterior chamber depth, lens thickness and intraocular lens calculation formula accuracy: nine formulas comparison.

Diogo Hipólito-Fernandes1, Maria Elisa Luís2, Rita Serras-Pereira2, Pedro Gil2, Vitor Maduro2, João Feijão2, Nuno Alves2.   

Abstract

BACKGROUND/AIMS: To investigate the influence of anterior chamber depth (ACD) and lens thickness (LT) on 9 intraocular lens (IOL) power calculation formulas accuracy, in patients with normal axial lengths.
METHODS: Retrospective case series, including patients having uncomplicated cataract surgery with insertion of a single IOL model, divided into three groups according to preoperative ACD. Each group was further subdivided into three subgroups, according to the LT. Using optimised constants, refraction prediction error was calculated for Barrett Universal II, Emmetropia Verifying Optical (EVO) V.2.0, Haigis, Hill-RBF V.2.0, Hoffer Q, Holladay 1, Kane, PEARL-DGS and SRK/T formulas. Mean prediction error, mean and median absolute error (MedAE) and the percentage of eyes within ±0.25D, ±0.50D and ±1.00D were also calculated.
RESULTS: The study included 695 eyes from 695 patients. For ACD ≤3.0 mm and ≥3.5 mm, mean prediction error of SRK/T, Hoffer Q and Holladay 1 was significantly different from 0 (p<0.05). PEARL-DGS, Kane, EVO V.2.0 and Barrett Universal II were more accurate than the Hoffer Q in ACD ≤3.0 mm (p<0.05). Kane, PEARL-DGS, EVO V.2.0 and Barrett Universal II revealed the lowest variance of mean and MedAE by ACD and LT subgroup. Haigis and Hill-RBF V.2.0 were significantly influenced by LT, independently of the ACD, with a myopic shift with thin lenses and a hyperopic shift with thick lenses (p<0.05).
CONCLUSION: New generation formulas, particularly Kane, PEARL-DGS and EVO V.2.0, seem to be more reliable and stable even in eyes with extreme ACD-LT combinations. © Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  anterior chamber; lens and zonules; optics and refraction; treatment surgery

Mesh:

Year:  2020        PMID: 33229347     DOI: 10.1136/bjophthalmol-2020-317822

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  6 in total

1.  Accuracy of new-generation intraocular lens calculation formulas in eyes with variations in predicted refraction.

Authors:  Pingjun Chang; Shuyi Qian; Yalan Wang; Siyan Li; Fuman Yang; Yiwen Hu; Zhuohan Liu; Yun-E Zhao
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-07-08       Impact factor: 3.117

2.  Comparison of accuracy of intraocular lens power calculation for eyes with an axial length greater than 29.0 mm.

Authors:  Chengyao Guo; Shengjie Yin; Kunliang Qiu; Mingzhi Zhang
Journal:  Int Ophthalmol       Date:  2022-05-10       Impact factor: 2.029

3.  Accuracy of intraocular lens power calculation in primary angle-closure disease: comparison of 7 formulas.

Authors:  Min Hou; Yujie Ding; Liangping Liu; Jianbing Li; Xing Liu; Mingxing Wu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-07-14       Impact factor: 3.117

4.  Development and Evaluation of the Prognostic Nomogram to Predict Refractive Error in Patients With Primary Angle-Closure Glaucoma Who Underwent Cataract Surgery Combined With Goniosynechialysis.

Authors:  Yuancun Li; Chengyao Guo; Chukai Huang; Liu Jing; Yingzi Huang; Ruiqing Zhou; Kunliang Qiu; Mingzhi Zhang
Journal:  Front Med (Lausanne)       Date:  2021-12-15

Review 5.  [Cataract surgery and the small eye: relative anterior microphthalmos, high hyperopia and nanophthalmos].

Authors:  Gerd U Auffarth; Tadas Naujokaitis; Maximilian Hammer
Journal:  Ophthalmologe       Date:  2021-08-27       Impact factor: 1.059

6.  Comparison of Formula-Specific Factors and Artificial Intelligence Formulas with Axial Length Adjustments in Bilateral Cataract Patients with Long Axial Length.

Authors:  Chuang Li; Mingwei Wang; Rui Feng; Feiyan Liang; Xialin Liu; Chang He; Shuxin Fan
Journal:  Ophthalmol Ther       Date:  2022-08-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.